2,4,6-Trinitrobenzenesulfonic acid
![]() | |
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name
2,4,6-Trinitrobenzene-1-sulfonic acid | |
| Other names
Picrylsulfonic acid; Trinitrobenzene sulfonate; TNBS
| |
| Identifiers | |
3D model (JSmol)
|
|
| 572358 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.017.925 |
| EC Number |
|
| 1051138 | |
PubChem CID
|
|
| UNII | |
| UN number | 0386 |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C6H3N3O9S | |
| Molar mass | 293.16 g·mol−1 |
| Density | 0.955 g/cm3 |
| Hazards | |
| GHS labelling: | |
![]() ![]()
| |
| Danger | |
| H317, H334 | |
| P261, P272, P280, P285, P302+P352, P304+P341, P321, P333+P313, P342+P311, P363, P501 | |
| NFPA 704 (fire diamond) | |
| Related compounds | |
Related compounds
|
Picric acid Trinitroanisole |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Trinitrobenzenesulfonic acid (C6H3N3O9S) is a nitroaryl oxidizing acid and explosive, used in biochemical research.
Uses
Its primary usage is primarily to neutralize peptide terminal amino groups in scientific research.[1] Occasionally it is used as a detonator for certain other explosive compounds.
The compound is currently being investigated for its effects on the immune system.[2] It is used to induce colitis in the colon of laboratory animals in order to model inflammatory bowel disease and post-infectious irritable bowel syndrome.[3]
Safety precautions
The compound has generally not been investigated for toxicity. However, the primary hazard of working with 2,4,6-trinitrobenzenesulfonic acid is the risk of explosion. Similar to other polynitroaryl acids (e.g. picric acid, TNT), 2,4,6-trinitrobenzenesulfonic acid can explode when heated strongly and mechanically disturbed, even in the presence of common phlegmatizers such as water. It will rapidly heat to ignition if exposed to medium-strong reducing agents, including hydrides, sulfides, and nitrides.[4]
References
- ^ Trinitrobenzenesulfonic Acid, Comparative Toxicogenomics Database.
- ^ Atsushi Kitani; Ivan J. Fuss; Kazuhiko Nakamura; Owen M. Schwartz; Takashi Usui; Warren Strober (2000). "Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (Tgf)-β1 Plasmid: TGF-β1–Mediated Suppression of T Helper Cell Type 1 Response Occurs by Interleukin (Il)-10 Induction and IL-12 Receptor β2 Chain Downregulation". The Journal of Experimental Medicine. 192 (1): 41–52. doi:10.1084/jem.192.1.41. PMC 1887715. PMID 10880525.
- ^ Antoniou, Efstathios; Margonis, Georgios Antonios; Angelou, Anastasios; Pikouli, Anastasia; Argiri, Paraskevi; Karavokyros, Ioannis; Papalois, Apostolos; Pikoulis, Emmanouil (2016-08-19). "The TNBS-induced colitis animal model: An overview". Annals of Medicine and Surgery. 11: 9–15. doi:10.1016/j.amsu.2016.07.019. ISSN 2049-0801. PMC 5021709. PMID 27656280.
- ^ Transport safety advice, via NOAA Office of Response and Restoration's CAMEO Chemicals, version 3.1.0 revision 2. Accessed 10 April 2026.





